Search Results

A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients from 1 Year to Less Than 18 Years Old Hospitalized with COVID-19

A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients from 1 Year to Less Than 18 Years Old Hospitalized

Charles W Heard, MD

Dr. Heard is a Board-Certified Orthopedic Surgeon at Baker, Heard, Osteen, and Davenport, MD, PA with a satellite office at Dr. P. Phillips Hospital. He graduated from the Medical College of Georgia with a MD degree. After two years of general surgery residency he completed four years of orthopedic surgery residency at the University of Texas Medical Center in Houston, Texas. He completed a fellowship in spinal disorders at the Robert Jones & Agnes Hunt Orthopedic Hospital in Oswestry, England before starting practice in Orlando in 1983.

James M Bowles, DC

A 4-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Pediatric Patients 6 to Less than 12 Years Old

A 4-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Pediatric Patients 6 to Less than 12 Years Old

Feeling “Spaced Out?” You May Need More Sleep

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/​Latina Adolescent and Young Adult Childhood Cancer Survivors

Walking Juntos: Developing and Testing a Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Adolescent Subjects with Moderately to Severely Active Ulcerative Colitis

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Social Genomic Mechanisms of Health Disparities among Adolescent and Young Adult (AYA) Survivors of Hodgkin and Non-Hodgkin Lymphoma

Association of Public Health Laboratories partners with Orlando Health, Florida Department of Health to launch system that enables faster test results sharing and enhances patient care

Orlando, FL (December 10, 2024) Orlando Health and Florida Department of Health are the first in the nation to use Detor, an Association of Public Health Laboratories (APHL) developed groundbreaking intermediary solution. Detor enables electronic test orders and results to be shared seamlessly between public health laboratories and healthcare providers.

Coalition for the Homeless

Call 407.426.1250